SAN DIEGO--(BUSINESS WIRE)--Accelrys, Inc. (NASDAQ:ACCL) today reported financial results for the quarter and full year ended March 31, 2007.
"We are pleased with our financial performance in fiscal 2007," said Mark J. Emkjer, Accelrys President and Chief Executive Officer. "We showed an approximately $6 million improvement in our bottom line and continued to generate positive cash flow, despite challenging market conditions and budget constraints experienced by our large pharmaceutical customers. Operationally, we delivered major new releases on time and with high quality across all of our product lines. These new releases add exciting technologies, substantially completing the modernization of our product portfolio.”
